IBD in 2016: Biologicals and biosimilars in IBD-the road to personalized treatment

Research output: Contribution to journal › Comment/Letter to the editor › Academic

6 Citations (Scopus)

Original language	English
Pages (from-to)	74-76
Number of pages	3
Journal	Nature Reviews Gastroenterology and Hepatology
Volume	14
Issue number	2
DOIs	https://doi.org/10.1038/nrgastro.2016.206
Publication status	Published - 1 Feb 2017

Access to Document

@article{a074974ddf79431b810e26cf241e05a0,

title = "IBD in 2016: Biologicals and biosimilars in IBD-the road to personalized treatment",

author = "Gecse, {Krisztina B.} and Lakatos, {P{\'e}ter L.}",

year = "2017",

month = feb,

day = "1",

doi = "https://doi.org/10.1038/nrgastro.2016.206",

language = "English",

volume = "14",

pages = "74--76",

journal = "Nature Reviews Gastroenterology and Hepatology",

issn = "1759-5045",

publisher = "Nature Publishing Group",

number = "2",

}

TY - JOUR

T1 - IBD in 2016

T2 - Biologicals and biosimilars in IBD-the road to personalized treatment

AU - Gecse, Krisztina B.

AU - Lakatos, Péter L.

PY - 2017/2/1

Y1 - 2017/2/1

UR - http://www.scopus.com/inward/record.url?scp=85009197990&partnerID=8YFLogxK

U2 - https://doi.org/10.1038/nrgastro.2016.206

DO - https://doi.org/10.1038/nrgastro.2016.206

M3 - Comment/Letter to the editor

C2 - 28074074

SN - 1759-5045

VL - 14

SP - 74

EP - 76

JO - Nature Reviews Gastroenterology and Hepatology

JF - Nature Reviews Gastroenterology and Hepatology

IS - 2

ER -